Newsfile (Fri, 26-Jun 3:42 PM ET)
Globe Newswire (Fri, 26-Jun 12:49 PM ET)
Globe Newswire (Fri, 26-Jun 10:59 AM ET)
Globe Newswire (Fri, 26-Jun 10:43 AM ET)
Globe Newswire (Thu, 25-Jun 7:55 PM ET)
PRNewswire (Thu, 25-Jun 2:51 PM ET)
TipRanks (Thu, 25-Jun 7:20 AM ET)
Phreesia Deadline: PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
PRNewswire (Wed, 24-Jun 7:57 PM ET)
Phreesia Shareholders Back Leadership, Governance at Annual Meeting
TipRanks (Wed, 24-Jun 4:36 PM ET)
10 small-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha News (Wed, 24-Jun 10:20 AM ET)
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of June 26, 2026, PHR stock price climbed to $10.07 with 2,409,339 million shares trading.
PHR has a beta of 1.18, meaning it tends to be more sensitive to market movements. PHR has a correlation of 0.06 to the broad based SPY ETF.
PHR has a market cap of $622.07 million. This is considered a Small Cap stock.
Last quarter Phreesia reported $131 million in Revenue and $.05 earnings per share. This beat revenue expectation by $823,792 and missed earnings estimates by -$.18.
In the last 3 years, PHR traded as high as $34.98 and as low as $7.77.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): VTI, IWM, VXF, IWO, FESM.
PHR has underperformed the market in the last year with a return of -63.5%, while the SPY ETF gained +21.3%. In the last 3 month period, PHR fell short of the market, returning -10.7%, while SPY returned +11.3%. However, in the most recent 2 weeks PHR has outperformed the stock market by returning +11.3%, while SPY returned -0.9%.
PHR support price is $8.79 and resistance is $9.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.